UPDATE 1-FDA declines to approve Adamis Pharma's Zimhi to treat opioid overdose
November 25, 2019 at 08:44 AM EST
Adamis Pharmaceuticals Corp said on Monday the U.S. Food and Drug Administration declined to approve its opioid overdose treatment, raising questions around its chemistry, manufacturing and controls (CMC).